| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.7M | +1.8% |
| Cost of Revenue | $1.7M | +170.6% |
| R&D Expense | $42.8M | -12.9% |
| SG&A Expense | $119.1M | -8.8% |
| Operating Income | -$573.0M | -208.0% |
| Interest Expense | $27.3M | +785.1% |
| Pre-tax Income | -$711.8M | -77.6% |
| Income Tax | $560K | — |
| Net Income | -$712.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $134.6M | -21.0% |
| Short-term Investments | $305.1M | -49.7% |
| Accounts Receivable | $245K | +1305.2% |
| Current Assets | $1.20B | +53.4% |
| Total Assets | $2.63B | +180.3% |
| Current Liabilities | $980.1M | +5564.8% |
| Long-term Debt | $947.1M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.8M | +124.2% |
| Capital Expenditures | $574K | -88.6% |
| Investing Cash Flow | -$2.27B | -266.5% |
| Financing Cash Flow | $2.25B | +165.4% |
| Free Cash Flow | $14.2M | +121.5% |
| -77.7% |
| EPS (Basic) | -$2.80 | -18.6% |
| EPS (Diluted) | -$2.80 | -18.6% |
| Total Liabilities |
| $982.8M |
| +3879.5% |
| Stockholders' Equity | $1.65B | +80.2% |